ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $783.81 million. The enterprise value is $601.71 million.

Market Cap	783.81M
Enterprise Value	601.71M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 34.21 million shares outstanding. The number of shares has increased by 316.83% in one year.

Current Share Class	34.21M
Shares Outstanding	34.21M
Shares Change (YoY)	+316.83%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	2.61%
Owned by Institutions (%)	54.61%
Float	15.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.83
P/TBV Ratio	3.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.34, with a Debt / Equity ratio of 0.00.

Current Ratio	14.34
Quick Ratio	13.63
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.00% and return on invested capital (ROIC) is -24.10%.

Return on Equity (ROE)	-49.00%
Return on Assets (ROA)	-23.10%
Return on Invested Capital (ROIC)	-24.10%
Return on Capital Employed (ROCE)	-49.57%
Revenue Per Employee	n/a
Profits Per Employee	-$2.45M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.90%
50-Day Moving Average	21.47
200-Day Moving Average	24.66
Relative Strength Index (RSI)	50.81
Average Volume (20 Days)	452,389

Short Selling Information

The latest short interest is 5.02 million, so 14.66% of the outstanding shares have been sold short.

Short Interest	5.02M
Short Previous Month	5.72M
Short % of Shares Out	14.66%
Short % of Float	31.70%
Short Ratio (days to cover)	14.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-100.41M
Pretax Income	n/a
Net Income	-127.46M
EBITDA	n/a
EBIT	-100.41M
Earnings Per Share (EPS)	-$3.78

Full Income Statement

Balance Sheet

The company has $176.08 million in cash and $138,000 in debt, giving a net cash position of $175.94 million or $5.14 per share.

Cash & Cash Equivalents	176.08M
Total Debt	138,000
Net Cash	175.94M
Net Cash Per Share	$5.14
Equity (Book Value)	202.54M
Book Value Per Share	5.95
Working Capital	172.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-119.59M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-316.83%
Shareholder Yield	-316.83%
Earnings Yield	-16.39%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $39.00, which is 70.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.00
Price Target Difference	70.23%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	10.70%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1